From CNBC

CVS has been ordered to cooperate with an investigation looking into false claim submissions and their pricing of insulin and epinephrine drugs. The article also describes a proposed class action lawsuit  pertaining to the increased prices of insulin against Sanofi, Eli Lilly & Co., and Novo Nordisk. Click here to learn more.